Save time and get answers to complex questions with AI chat
Pramlintide fda approval date?When will tenofovir alafenide come off patent in canada?Drugpatentwatch skyrizi biologic patent analysis?Abbvie humira patent cliff navigation success?Defense strategy against generic in niche market?
See the DrugPatentWatch profile for prolia
Prolia (denosumab) was first approved and launched by Amgen in 2010. [1]
Because the initial approval and market entry were in 2010, Prolia is often described as a 2010 product. [1]
Yes. Prolia was introduced as a new therapy in 2010, with denosumab representing a specific approach for osteoporosis treatment. [1] Sources: [1] https://www.drugs.com/history/prolia.html
Other Questions About Prolia :